Home | About IJMPO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Reader Login
Indian Journal of Medical and Paediatric Oncology
Search Article 
Advanced search 
Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   1998| March  | Volume 19 | Issue 1  
    Online since May 30, 2009

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
Recombinant human erythropoietin therapy for cisplatin associated anaemia : a pilot study.
L Kumar, YH Pohkarel, H Pati, V Kochupillai
March 1998, 19(1):3-8
Sixteen patients with cisplatin associated anaemia (haemoglobin less than 9 gm per cent) received recombinant human erythropoietin (EPO), 50 U/kg subcutaneously three times a week for three weeks on an out patient basis. Seven of fifteen patients responded (increase in haemoglobin to greater than 10 g per cent); six following an well; headache, fatigue, nausea and feverish feeling being the main side effects. No episodes of hypertension or thrombo-haemorrhagic complications were detected. We conclude that recombinant human erythropoietin is safe and well tolerated in the recombinant human erythropoietin is safe and well tolerated in the treatment of cisplatin induced anaemia. It results in response rate of about 50 per cent following low dose treatment (50 U/kg three times a week). Further studies are needed to determine the optimum dose. schedule of EPO therapy and its impact on transfusion requirements.
[ABSTRACT]   Full text not available   
  680 0 -
Profile of hepatitis in cancer patients.
SA Aziz, M Ahmed, GM Bhat, BA Lone
March 1998, 19(1):19-22
During the period of July 1993 till March 1995, 409 new admissions were made in the Department of Medical Oncology, SKIMS (230 males, 179 females). Of these 23 patients were diagnosed to have hepatocellular jaundice of infectious aetiology (13 males and 10 females). Hepatitis B was seen in 9 patients (2.20 per cent), Hepatitis C in 5 patients (1.22 percent), Hepatitis E in 4 patients (0.97 per cent), the nature of infection could not be ascertained. Protracted clinical course including short incubation period, prolonged icteric stage and convalescence were observed, Indices of liver cell damage were elevated much more than the patients of uncomplicated hepatitis. Histopathological features were identical to those seen in uncomplicated hepatitis. There were 9 deaths (39.1 per cent) attributable to hepatocellular failure in these patients. Female sex, higher values of bilirubin and liver enzymes, low serum albumin and deranged coagulation indices were identified as bad prognostic factors.
[ABSTRACT]   Full text not available   
  640 0 -
Chemotherapy for non Hodgkin's lymphoma during pregnancy and fetal outcome.
NR Tulasi, Banumathi, G Srimathi, A Sirvatham, V Nagaran
March 1998, 19(1):23-24
Fetal outcome is major source of worry whenever treatment is undertaken for malignancy in pregnancy. Here, we present a case of Non-Hodgkin's Lymphoma in primi who underwent combination chemotherapy from the 4th month of pregnancy to labour and the follow-up of the child. To our knowledge, in the literature survey done, no similar case has been reported in Indian literature.
[ABSTRACT]   Full text not available   
  620 0 -
Pericardial mesotheliomas : a report of two cases.
DC Doval, CR Rao, R Acharya, s Misra, L Narasimhan, M Chandrashekhar, PP Bapsy
March 1998, 19(1):13-18
Pericardial mesothelioma is a rare tumour. Ante mortem diagnosis is seldom made and approximately 75 per cent of the cases described in the literature have been diagnosed at autopsy. Two cases of pericardial mesothelioma diagnosed after surgical intervention are presented and the relevant literature discussed.
[ABSTRACT]   Full text not available   
  616 0 -
Acute promyelocytic leukaemia : the era of ATRA.
VP Gangadharan, NP Prakash, ES Koshy
March 1998, 19(1):9-12
Acute Promyelocytic leukaemia (APL) is a rare type of leukaemia representing 5-15 per cent cases of ANLL1. The characteristic chromosomal translocation involving chromosomes 15 and 172, increased propensity for DIC3,4 and the dramatic response to All Trans Retinoic Acid (ATRA), make APL unique among acute leukemias. Remission induced by ATRA has to be consolidated 5,6. Therapeutic options in treating DIC is controversial. We analysed 6 cases of APL treated with ATRA; 40 percent achieved a complete remission (CR)
[ABSTRACT]   Full text not available   
  497 0 -
Erythropoietin : the flag of transfusion independence (editorial).
S Agarwal
March 1998, 19(1):1-2
Full text not available   
  368 0 -
National training project report on : first national trainer's workshop in practical paediatric oncology.
BR Agarwal
March 1998, 19(1):30-36
Full text not available   
  343 0 -